This coupled decrease in both bone formation (BSAP) and resorption (TRAP-5b) markers suggests an overall trend toward reduced bone turnover.
← all excerpts
Impact of dapagliflozin on bone mineral metabolism in non-diabetic patients with chronic kidney disease: a randomized, double-blind, placebo-controlled study.
1
—
—